Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CME Group
CME
|
+$322M |
| 2 |
UnitedHealth
UNH
|
+$233M |
| 3 |
Microsoft
MSFT
|
+$198M |
| 4 |
International Flavors & Fragrances
IFF
|
+$171M |
| 5 |
Principal Financial Group
PFG
|
+$169M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$714M |
| 2 |
IBM
IBM
|
+$395M |
| 3 |
Cisco
CSCO
|
+$303M |
| 4 |
Procter & Gamble
PG
|
+$290M |
| 5 |
Macy's
M
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.98% |
| 2 | Financials | 14.9% |
| 3 | Healthcare | 12.91% |
| 4 | Industrials | 10.1% |
| 5 | Consumer Discretionary | 9.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ABCO
1976
DELISTED
Advisory Board Co
ABCO
| $9.45M | ﹤0.01% |
284,331
+23,757
| +9% | +$878K |
|
1977
Matrix Service
MTRX
$335M
| $9.43M | ﹤0.01% |
415,171
+37,449
| +10% | +$745K |
|
|
EXTN
1978
DELISTED
Exterran Corporation
EXTN
| $9.42M | ﹤0.01% |
394,208
+22,834
| +6% | +$433K |
|
|
DOOR
1979
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $9.41M | ﹤0.01% |
142,952
+29,249
| +26% | +$1.83M |
|
1980
National Healthcare
NHC
$3.5B
| $9.4M | ﹤0.01% |
124,063
+27,447
| +28% | +$1.9M |
|
|
FRGI
1981
DELISTED
Fiesta Restaurant Group, Inc.
FRGI
| $9.39M | ﹤0.01% |
314,441
+9,327
| +3% | +$259K |
|
1982
WisdomTree US MidCap Dividend Fund
DON
$4.13B
| $9.38M | ﹤0.01% |
298,038
+95,604
| +47% | +$2.92M |
|
1983
Tredegar Corp
TG
$276M
| $9.37M | ﹤0.01% |
390,361
-9,938
| -2% | -$209K |
|
1984
Ironwood Pharmaceuticals
IRWD
$712M
| $9.34M | ﹤0.01% |
729,632
+35,647
| +5% | +$450K |
|
1985
Credit Acceptance
CACC
$6.1B
| $9.32M | ﹤0.01% |
42,837
+5,203
| +14% | +$1.01M |
|
1986
Vale
VALE
$58B
| $9.3M | ﹤0.01% |
1,220,904
+16,650
| +1% | +$122K |
|
1987
iShares International Select Dividend ETF
IDV
$8.59B
| $9.28M | ﹤0.01% |
313,846
-21,634
| -6% | -$632K |
|
1988
Quanex
NX
$962M
| $9.27M | ﹤0.01% |
456,864
+34,428
| +8% | +$637K |
|
|
DEL
1989
DELISTED
Deltic Timber
DEL
| $9.25M | ﹤0.01% |
120,073
+4,850
| +4% | +$331K |
|
|
EGRX
1990
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $9.25M | ﹤0.01% |
116,608
+23,343
| +25% | +$1.7M |
|
1991
SunCoke Energy
SXC
$794M
| $9.25M | ﹤0.01% |
815,659
+106,993
| +15% | +$1.14M |
|
|
MRC
1992
DELISTED
MRC Global
MRC
| $9.25M | ﹤0.01% |
456,416
-25,389
| -5% | -$462K |
|
1993
Marcus Corp
MCS
$925M
| $9.22M | ﹤0.01% |
292,592
+11,338
| +4% | +$321K |
|
|
KITE
1994
DELISTED
Kite Pharma, Inc.
KITE
| $9.2M | ﹤0.01% |
205,243
-2,228
| -1% | -$109K |
|
|
NVRO
1995
DELISTED
NEVRO CORP.
NVRO
| $9.2M | ﹤0.01% |
126,577
-23,074
| -15% | -$1.98M |
|
|
VRN
1996
DELISTED
Veren
VRN
| $9.15M | ﹤0.01% |
673,089
+85,060
| +14% | +$1.09M |
|
|
MEG
1997
DELISTED
Media General, Inc
MEG
| $9.15M | ﹤0.01% |
485,768
-639,902
| -57% | -$11.6M |
|
|
ALJ
1998
DELISTED
Alon USA Energy Inc
ALJ
| $9.14M | ﹤0.01% |
803,569
+234,343
| +41% | +$2.2M |
|
|
PPBI
1999
DELISTED
Pacific Premier Bancorp
PPBI
| $9.13M | ﹤0.01% |
258,207
+41,063
| +19% | +$1.23M |
|
|
FMSA
2000
DELISTED
Fairmount Santrol Holdings Inc.
FMSA
| $9.11M | ﹤0.01% |
772,811
+262,979
| +52% | +$2.43M |
|
Similar funds
Bank of New York Mellon's Q4 2016 Portfolio in Review
As of Q4 2016, Bank of New York Mellon held 4,430 positions worth $347B, up 3.3% from $336B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Bank of New York Mellon's Q4 2016 filing shows 161 new, 2,590 increased, 1,402 reduced and 170 closed positions. Its largest new stake was Lamb Weston: 2,449,932 shares worth $92.7M. The largest sale was Merck, an estimated $714M.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.
- Bank of New York Mellon's largest Q4 2016 buy was Lamb Weston: 2,449,932 shares worth $92.7M.
- Bank of New York Mellon added most to CME Group in Q4 2016, an estimated $322M increase.
- Bank of New York Mellon's biggest Q4 2016 reduction was Merck, cutting an estimated $714M.
- Bank of New York Mellon fully exited LinkedIn Corporation in Q4 2016, selling an estimated $82.8M.
- Bank of New York Mellon's ten largest holdings make up 13% of its $347B portfolio in Q4 2016.
- Bank of New York Mellon opened 161 new positions and closed 170 in Q4 2016.
- Bank of New York Mellon's portfolio value rose 3.3% quarter-over-quarter to $347B.
Based on Bank of New York Mellon's 13F filing for Q4 2016, filed 13 Feb 2017.